Scientific connotation of “treating different diseases with the same method” from the perspective of metabolic-immune dysregulation in inflammation-mediated carcinogenesis of digestive organs

Inflammation-mediated carcinogenesis develops in the context of chronic inflammation and is a significant cause of cancer within the digestive system.In the chronic inflammation microenvironment,the metabolic activity of tissue cells undergoes extensive changes,which interfere with the normal function of immune cells.Dysregulation of cell metabolism and immune function has been identified as a key factor contributing to inflammation-mediated carcinogenesis within the major digestive organs,such as the stomach,liver,and colorectum.This metabolic-immune imbalance also corresponds to traditional Chinese medicine(TCM)theories of“yin-yang disharmony”and“disharmony between Ying-nutrients and Wei-defense.”The metabolic-immune imbalance has also been regarded as the key factor supporting“treatment of different diseases with the same method”,in which the same approach is adopted in the treatment of different conditions.In the TCM treatment process,it is necessary to first identify TCM patterns and then apply the corresponding TCM to correct the dysregulated metabolic and immune function,thereby blocking the progression from inflammation to malignancy.Our study findings deepen the TCM understanding of metabolic-immune dysregulation and the relationship between metabolic-immune dysregulation,pattern identification,and treatment method.They also provide new insights for the treatment of inflammation-mediated carcinogenesis in major digestive organs and help us further explore the scientific connotation of the TCM strategy of“treating different diseases with the same method”.

Cone beam computed tomography-guided differences among registration methods for lung cancer and the effects of tumor position,treatment model,and tumor size on positioning errors

Objective To explore the differences in three different registration methods of cone beam computed tomography(CBCT)-guided down-regulated intense radiation therapy for lung cancer as well as the effects of tumor location,treatment mode,and tumor size on registration.Methods This retrospective analysis included 80 lung cancer patients undergoing radiotherapy in our hospital from November 2017 to October 2019 and compared automatic bone registration,automatic grayscale(t+r)registration,and automatic grayscale(t)positioning error on the X-,Y-,and Z-axes under three types of registration methods.The patients were also grouped according to tumor position,treatment mode,and tumor size to compare positioning errors.Results On the X-,Y-,and Z-axes,automatic grayscale(t+r)and automatic grayscale(t)registration showed a better trend.Analysis of the different treatment modes showed differences in the three registration methods;however,these were not statistically significant.Analysis according to tumor sizes showed significant differences between the three registration methods(P<0.05).Analysis according to tumor positions showed differences in the X-and Y-axes that were not significant(P>0.05),while the autopsy registration in the Z-axis showed the largest difference in the mediastinal and hilar lymph nodes(P<0.05).Conclusion The treatment mode was not the main factor affecting registration error in lung cancer.Three registration methods are available for tumors in the upper and lower lungs measuring<3 cm;among these,automatic gray registration is recommended,while any gray registration method is recommended for tumors located in the mediastinal hilar site measuring<3 cm and in the upper and lower lungs≥3 cm.

The Pathogenetic Concept of the Diagnostic-Treatment Approach for Patients with Purulent-Septic Complications

Background: The significant improvement of immediate and long-term functional results of treating patients is the fundamental problem of modern medical science. A deep understanding of the pathogenesis is the key point in creating the management strategy for patients with various diseases. Information about the mechanisms of origin and development of purulent-inflammatory diseases and sepsis is essential for finding effective ways to prevent and treat them. The aim of the research is to use the method of fluorescence spectroscopy in creating the pathogenetic diagnostic and treatment model for the prevention and treatment of purulent-inflammatory diseases and sepsis, modification of treatment tactics, search for new markers of purulent-septic diseases, as well as monitoring of patients during the treatment. Materials and methods: The proposed approach, along with standard diagnostic methods, was used to organize the treatment process of 100 patients with purulent-inflammatory diseases, including 15 patients with sepsis, 35 with acute inflammatory abdominal pathology, 20 patients with burn injury (main group) and 35 patients with burn injury (comparison group). Results: The behavior of spectral-fluorescent characteristics in their dynamics has been studied, and the new markers for assessing patients’ conditions have been proposed. Their effectiveness for the diagnosis of purulent-septic diseases has been proved, which advances the results of standard research methods by 24 - 48 hours. Conclusions: The proposed diagnostic and treatment approach is fundamentally important for diagnosis and monitoring during the treatment of patients with purulent-septic diseases. Particularly relevant is the proposal to modify the treatment process for these patients, associated with the use of infusion of donor albumin solutions.

Current Problems of the Diagnostics and Treatment of Sepsis and Burn Injuries: The Modified Pathogenetic Concept

Background: The deep understanding of pathogenesis is a key moment in the formation of the modern strategy of modern medicine. We conducted the thorough analysis of the microscopic processes occurring in the bodies of patients with purulent-septic complications. The modified pathogenetic concept of the diagnostic and treatment model of diseases with septic complications is presented. The obtained information about the mechanisms of origin and development of these diseases is fundamentally important for finding the modern effective methods of treating patients. The aim of the research is to modify treatment tactics for patients with sepsis and burn injuries based on the modified pathogenetic concept using modern diagnostics, i.e. the method of fluorescence spectroscopy (MFS) and biomarkers. Materials and Methods: The proposed modified pathogenetic concept of the diagnostic and treatment model of diseases with purulent-septic complications along with standard methods was used successfully for effective treatment of 15 patients with sepsis and 25 with burn injuries. Results: 3 main scenarios of behaviour of spectral-fluorescence characteristics of patients with sepsis are illustrated. Spectral-fluorescence markers of sepsis were studied, which are informative 24 to 48 hours before the appearance of obvious clinical and laboratory signs of significant changes in the general somatic status of patients. Conclusions: The proposed diagnostic and therapeutic approach is new and fundamentally important for diagnostics and monitoring of the process of treatment of patients with purulent-septic diseases and burn injuries. An in-depth understanding of the dynamics of septic complications and the corresponding changes of the main markers of these diseases during treatment is especially relevant. The use of infusion therapy with solutions of donor albumin as an effective pathogenetic treatment is scientifically justified.

部分嵌套式设计在中医药“同病异治”疗效评价中的应用及方法学探索

目的本研究针对中医学同病异治、辨证论治的特征,引入部分嵌套式设计。方法部分嵌套式设计以复杂干预对照标准化治疗,中医组按“证型-治法-方药”分割为多个子集(存在嵌套结构),对照组采用标准化西医治疗(无嵌套结构);并以一项溃疡性结肠炎“同病异治”数据为例,套用该设计类型并采用多水平模型分析。结果部分嵌套式设计符合“同病异治”诊疗特征并满足循证评价的设计要求,通过多水平模型可实现类似数据结构的分析。结论利用部分嵌套式设计能实现对“同病异治”整体效果的评价,可为中医药临床疗效评价提供方法学参考。

桂枝茯苓丸化裁异病同治血瘀型功能性肛门直肠痛经验

目的总结运用桂枝茯苓丸化裁治疗血瘀型功能性肛门直肠痛的诊疗思路。方法通过研究古籍、搜集整理文献、整理验方,结合现代医家研究,从病因病机、用药特点等方面,分析总结运用桂枝茯苓丸化裁治疗血瘀型功能性肛门直肠痛的诊疗思路,并列举验案加以佐证。结果功能性肛门直肠痛始于气机升降功能的紊乱,血瘀是该病最终趋势,活血化瘀是中医辨治功能性肛门直肠痛的核心方法。结论桂枝茯苓丸在临床中多用于治疗妇科相关疾病,以异病同治创新性地将其引入血瘀型功能性肛门直肠痛的治疗中,临证经验提示疗效显著,为功能性肛门直肠痛的临床诊治提供了新的思路。

Network pharmacology unveils spleen-fortifying effect of Codonopsis Radix on different gastric diseases based on theory of “same treatment for different diseases” in traditional Chinese medicine

Objective: "Same treatment for different diseases" is a unique treatment strategy under the guidance of traditional Chinese medicine(TCM) theory.Codonopsis Radix(Codonopsis pilosula,Dangshen in Chinese)with spleen-fortifying effect was employed to understand the strategy of "Same treatment for different diseases",based on its common mechanism in the treatment of gastric diseases including gastric ulcer,gastritis and gastric cancer via network pharmacology research.Methods:Network pharmacology research methods were used to analyze the interaction network and potential mechanisms of Dangshen in treating gastric ulcer,gastritis and gastric cancer.The active components and their target proteins of Dangshen were integrated from TCMSP,BATMAN-TCM databases.The targets of gastric ulcer,gastritis and gastric cancer were collected through GeneCards,PubMed,TDD and DisGeNET Database.Through screening,the key components and the key targets of Dangshen in treating gastric ulcer,gastritis and gastric cancer were obtained.After KEGG pathway analysis and GO analysis,the important pathways and biological processes were analyzed.Results:Through data and literature mining,the common and specific pharmaceutical effects and mechanism of Dangshen were summarized in these three gastric lesions.It was shown that Dangshen mainly acted on gastric ulcer,gastritis and gastric cancer through the overall regulation of the PI3K-AkT signaling pathway.With the development of the disease,it will gradually increase the control of inflammation through TNF,NF-κB and other inflammation-related signaling pathways to reduce inflammatory damage.For tumorigenesis,it pays more attention to inhibiting the ErbB signaling pathways to reduce the proliferation and migration of tumor cells.In addition,Dangshen's regulation of HIF-1 signaling pathway may also be beneficial for the treatment of gastric ulcer,gastritis and gastric cancer.Conclusion:Dangshen achieves spleen-fortifying effect on gastric diseases including gastric ulcer,gastritis and gastric cancer through multiple targets in multiple pathways,especially PI3K-AKT pathway and HIF-1 pathway.It could provide a scientific basis for understanding the strategy of "Same treatment for different diseases" in traditional Chinese medicine.

基于治未病理论探讨“扶卫气法”预防放射性皮炎

本文提出,体内营卫正气损伤,尤其是放射线引起卫气损耗是放射性皮炎发病的主要原因,临床防治放射性皮炎应以预防为主,保护卫气功能,扶正卫气,以加强护卫肌表、防御外邪之功,提出“扶卫气法”预防放射性皮炎,拟定以大剂量黄芪为君药的预防、减轻或治疗放射性皮炎外用方剂。

伏风理论指导儿科过敏性疾病辨证论治

提出特禀质儿童的体质特点是伏风内潜,一旦患儿为外来“虚邪贼风”所引,则发生如鼻鼽、风咳、哮喘、风瘾、湿疹等“风病”(过敏性疾病)。这类风病治疗应当以消风法为主,辨证配用散邪、除湿、润燥、豁痰、凉血、养血、固表等治法治疗。介绍了如何以伏风理论认识小儿鼻鼽、风咳、哮喘、风瘾、湿疹等过敏性疾病的病因病机、临床辨证,以及以消风法为主治疗这些疾病的有效经验方药。

基于网络药理学与分子对接技术探讨半夏厚朴汤“异病同治”胃食管反流病和慢性咽炎的作用机制

目的 基于中医学“异病同治”理论,运用网络药理学与分子对接技术探究半夏厚朴汤治疗胃食管反流病(GERD)和慢性咽炎的作用机制。方法 通过中药系统药理学数据库与分析平台、本草组鉴数据库、中医药百科全书数据库检索半夏厚朴汤活性成分及潜在靶点;通过GeneCards、TTD和OMIM数据库获得GERD和慢性咽炎相关靶点;通过Venny平台筛选药物与两种疾病的共同靶点;通过Cytoscape 3.9.1软件构建“药物-活性成分-共同靶点-疾病”网络,以展示其交互作用关系;通过STRING平台构建共同靶点PPI网络;通过Metascape平台对共同靶点进行GO功能及KEGG通路富集分析;运用Schr9dinger Suite对关键靶点和所有活性成分进行分子对接,验证潜在作用靶点与药物成分的结合能力,并筛选出主要活性成分。结果 共筛选半夏厚朴汤活性成分46个,得到药物靶点223个,共获得GERD疾病靶点2 170个,慢性咽炎疾病靶点402个,筛选得到疾病与药物共有靶点59个;其中核心靶点涉及IL-6、TNF、AKT1、IL-1β、VEGFA等;GO分析显示,共有靶点主要参与细胞群增殖的负调控、细胞转运的正向调控、炎症应答等生物过程;KEGG富集结果显示,共有靶点与癌症通路、JAK-STAT、NF-κB等信号通路相关。分子对接结果显示,核心蛋白与大多数活性成分存在结合位点,其中槲皮素、(+)-儿茶素、刺槐苷B、黄芩苷、鞣花酸等成分与核心靶点结合较为稳定,可推测为“异病同治”主要成分。结论 半夏厚朴汤可通过多成分、多靶点、多通路抑制细胞凋亡、减少炎症反应以及调节免疫等发挥对GERD和慢性咽炎的“异病同治”作用。

从气血同治探讨慢性气道疾病的异病同治

支气管哮喘和慢性阻塞性肺疾病(简称慢阻肺)同属慢性气道炎症疾病,在病机和治法上有一定的相似性,其都可通过调节气血以恢复肺气宣肃,行使正常生理功能。针对肺的生理功能和气血的关系,探讨支气管哮喘和慢阻肺的共同病机:支气管哮喘的基本病机是痰伏于肺,外邪引动,痰气互结,肺失宣降,并可兼有瘀血阻络之象;慢阻肺的病机以久病肺虚为本,加之痰浊、水饮、瘀血等病理产物,使得肺失宣降,本虚标实的病机随病程持续进展;进而从气血同治角度探讨支气管哮喘和慢阻肺2种慢性气道疾病的异病同治,得出“气血同治,畅通气道”的治疗理念。结合成药的应用,分析以此病机为指导的丹龙口服液组方特点和功效主治,为丹龙口服液异病同治2种气道疾病提供理论依据。

刘良徛“全程温法治疗肺纤维化”思想在系统性硬化症相关间质性肺病中的应用

刘良徛在继承国医大师洪广祥“治肺不远温”思想基础上,创新提出“全程温法治疗肺纤维化”的学术观点,认为“阳虚寒凝、痰滞血瘀”为肺纤维化的核心病机。系统性硬化症相关间质性肺病属于慢性肺纤维化的范畴,其中医病机与上述相一致。治疗上予以温阳散寒、涤痰行瘀,温肺化纤汤为其有效方剂。现总结刘良徛诊治系统性硬化症相关间质性肺病的学术思想及临床经验,以期为该病的中医治疗提供参考。

基于德尔菲法的《脑卒中“病脉证并治”临床辅助决策方案》条目筛选

目的对《脑卒中“病脉证并治”临床辅助决策方案》进行条目筛选,为方案制定和完善提供参考。方法采用德尔菲法,通过问卷星平台于2022年7、8月分别向全国60位脑病学或神经病学方向专家发放两轮问卷,对方案的病名概述、病因病机、证候特点、治则治法、代表方、针灸及其他疗法与预防调护具体条目问卷结果进行统计学分析。结果两轮调查分别回收42、50份有效问卷。专家对病因病机、治则治法、针灸及其他疗法、预防调护条目重要性达成共识。证候特点删除了与证型相关度低或引起歧义的要素,代表方删除现代已弃用或同名异方。同时,对证型、治则治法的名称进行统一规范化处理。结论《脑卒中“病脉证并治”临床辅助决策方案》条目基本得到专家认同,但仍存在局限性,有待进一步研究探讨。

设立产业转型升级示范区对企业融资约束的影响——基于交错双重差分模型

本文以产业转型升级示范区设立作为准自然实验,利用2010-2019年中国A股上市公司数据,采用交错双重差分模型考察了示范区政策对企业融资约束的影响及作用路径,并充分探讨了交错双重差分模型的处理效应异质性。研究发现,示范区设立以后,能够显著缓解辖区内企业的融资约束,并且政策效果具有持续性,上述结论在考虑交错双重差分模型的处理效应异质性以及一系列识别假定检验和稳健性检验后依然成立。机制分析表明,扩大企业融资来源和降低企业经营成本是示范区政策缓解企业融资约束的重要途径。宏观层面加强政府调节,坚持市场导向,进一步扩大开放,能够有效吸引金融机构和投资者参与示范区建设,助力示范区企业资金融通,对缓解示范区企业的融资约束具有积极作用。此外,示范区政策的实施,为企业发展创造了良好的营商环境,吸引大量新企业入驻,激发了企业创新转型发展的内生动力,提升了企业的全要素生产率水平,具有显著的经济效益。本文的结论有助于拓展宏观产业政策与企业行为的研究框架,对进一步完善示范区政策具有重要启示。

基于血水同治法刍议当归贝母苦参丸之异病同治

目的 基于血水同治法刍议当归贝母苦参丸之异病同治。方法 以血水同治法为理论依据,结合当归贝母苦参丸之组方原理,探讨其异病同治之临床应用。结果 当归贝母苦参丸为血水同治法代表方剂,为治疗妇女妊娠并发小便难之名方。现代中医学者基于其血水同治的组方思路,扩展其临床应用,如盆腔炎、前列腺炎、慢性便秘、溃疡性结肠炎,以及肿瘤类疾病。结论 当归贝母苦参丸之异病同治皆为其血水同治之配伍功效与多种疾病之病机吻合,临证之时应灵活加减。

基于络病学说从血络气络论治血管性痴呆

血管性痴呆(VD)是脑血管病变导致的认知功能障碍,发病率逐年上升。中医称为“呆病”“善忘”“痴呆”。现代医家对络病理论不断深入,广泛将其应用于临床。络脉-络病学说相关文献研究发现,络脉病变对VD发病的影响较大,其中气郁、痰浊、血瘀导致的血络瘀阻是VD的基本病机,病理产物蕴积生毒,毒邪滞络进而损害血络。气络中真气、宗气、卫气、营气受损则导致神经-内分泌-免疫(NEI)网络受损,致脑神失用。血络、气络共同作用于VD。

按病种付费对中医优势病种住院费用的影响研究——基于PSM-DID法

目的:分析按病种付费对中医优势病种住院费用的影响,为中医按病种付费改革提供参考。方法:采用某中医医院实施按病种付费的高位肛瘘患者住院费用数据,经倾向得分匹配法(PSM)匹配后,进行双重差分(DID)回归分析,探讨按病种付费对中医优势病种住院费用的影响。结果:实施按病种付费后,高位肛瘘患者住院总费用下降了1067.63元、自付费用下降了656.66元、住院天数缩短了5.54天、西药费增长了406.55元、中成药费下降了126.80元。结论:在中医优势病种按病种付费过程中,应加强医保监督,持续完善、更新中医信息系统,扩大按病种付费的中医优势病种范围,突出中医临床路径优势,促进中医药传承创新发展。

阿尔茨海默病不同治疗方式研究新进展

阿尔茨海默病(Alzheimer’s disease,AD)是一种复杂的、起病隐秘的、病因不明的、缺乏特异性诊断方式的神经退行性病变。面对与日俱增的患病率,却缺乏有效的治疗方式。中医药治疗方式具有多层次、多靶点、多通路的独特优势,中西医结合方式的互补,非药物疗法的辅助,干细胞疗法、新的分子药物、抗体及蛋白疫苗、γ感官刺激等新颖的实验阶段新疗法等方式治疗AD。本文综述近年来的不同治疗方式治疗AD研究新进展,旨在为临床上治疗AD提供新思路、新方法及参考价值。

李飞针灸治疗面瘫经验举隅

总结李飞教授治疗面瘫的学术思想及诊疗经验。李飞提出诊治面瘫时应遵循“初病审因,次探病机,再明病证,辨证论治”,以祛风通络、疏调筋经为基本治疗原则。临床治疗时,以“重视解剖,依症施治”为基本方针,贯通中西理论,结合表情肌解剖结构,动态化判断神经、肌肉恢复情况,依据症状选取相应经验组穴。重视整合理论,总结理法辨证、分期辨证、症状辨证之“辨证三重”法则,调经、调筋、调神之“治疗三调”理论,值得临床借鉴。

基于《治肝三十法》探析从肝论治间质性肺疾病咳嗽

清代医家王旭高以肝气、肝火、肝风、肝虚为纲,总结创立了《治肝三十法》。以《治肝三十法》为立足点探析肝气、肝火、肝风、肝虚的源流及内涵,并探讨间质性肺疾病的病机变化与其相似之处,从而提出从肝论治间质性肺疾病咳嗽,分析并探索间质性肺疾病相关咳嗽的临床用药规律及有效方剂,并应用典型案例验证其临床疗效,希望能对中医辨治间质性肺疾病相关咳嗽提供新的思路及方法。